文献速递消化道肿瘤放疗姑息放疗与转移瘤

胸段食管鳞癌颈部淋巴结转移模式或影响根治性放疗靶区决策

The pattern of cervical lymph node metastasis in thoracic esophageal squamous cell carcinoma may affect the target decision for definitive radiotherapy.
PubMed 文献 · Radiother Oncol · 2017-05-24

该回顾性研究纳入1715例接受三野淋巴结清扫根治性食管切除术的胸段食管鳞癌患者,病理证实颈部淋巴结转移率为31.9%,上、中、下胸段分别为44.2%、31.5%、14.4%。多因素分析仅肿瘤部位和pN状态与颈部淋巴结转移独立相关,转移最常见于食管旁区(72.3%),其次为锁骨上(24.4%),深颈部和咽后罕见。

要点

  • 胸段食管鳞癌颈部淋巴结转移率31.9%,上胸段最高(44.2%),下胸段最低(14.4%)。
  • 多因素分析仅肿瘤部位和pN状态与颈部淋巴结转移独立相关。
  • 颈部阳性淋巴结最常见于食管旁区(72.3%),锁骨上区24.4%,深颈部2.4%,咽后0.9%。

核心结论

  • 上胸段食管鳞癌伴任何部位多发淋巴结受累与高颈部淋巴结转移率相关,可为淋巴结清扫范围或根治性放疗照射野大小的临床决策提供信息。

研究设计与样本

  • 回顾性分析1993年1月至2007年3月在本院接受根治性食管切除术加三野淋巴结清扫的1715例患者的记录。
  • 纳入患者均为病理确诊的胸段食管鳞癌且无颈部转移临床证据。

主要发现

  • 547例(31.9%)发现颈部淋巴结转移,上胸段、中胸段、下胸段肿瘤的颈部淋巴结阳性率分别为44.2%、31.5%、14.4%。
  • 单因素分析显示颈部淋巴结转移与肿瘤部位、分化程度、长度、病理T分期和pN状态相关(P<0.05)。
  • 多因素分析仅肿瘤部位和pN状态保留显著性(P<0.05)。
  • 颈部阳性淋巴结最常见于食管旁区(72.3%),其次为锁骨上(24.4%),深颈部(2.4%)或咽后淋巴结(0.9%)受累罕见(P<0.0001)。
  • 颈部阳性淋巴结最常与上胸段食管鳞癌相关(60.1%),其次为中胸段(31.2%)和下胸段(10.6%)。

关键数值与推荐

  • 颈部淋巴结转移率:总体31.9%,上胸段44.2%,中胸段31.5%,下胸段14.4%。
  • 颈部阳性淋巴结分布:食管旁区72.3%,锁骨上24.4%,深颈部2.4%,咽后0.9%(P<0.0001)。
  • 颈部阳性淋巴结与肿瘤部位关联:上胸段60.1%,中胸段31.2%,下胸段10.6%。

临床怎么用

  • 上胸段食管鳞癌伴多发淋巴结受累时颈部淋巴结转移率高,根治性放疗制定靶区时需重点考虑颈部淋巴结引流区。
  • 颈部淋巴结转移最常见于食管旁区和锁骨上区,深颈部和咽后受累罕见,可据此优化照射野范围。

局限性

  • 本研究为单中心回顾性分析,基于手术病理结果,可能不直接等同于根治性放疗患者的临床情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Metastasis to lymph nodes is a key determinant of thoracic esophageal squamous cell carcinoma (TE-SCC) prognosis. We sought to identify factors linked with cervical lymph node metastasis, which could be used to inform the decision of surgical and definitive radiotherapy. METHODS: We retrospectively reviewed records from 1715 patients who had had radical esophagectomy with three-field lymphadenectomy between January 1993 and March 2007 in our hospital. All patients included in the study had pathologically confirmed TE-SCC and no clinical evidence of cervical metastasis. RESULTS: Cervical node metastases were found in 547 patients (31.9%); rates of cervical-node positivity were 44.2% for those with upper-thoracic tumors, 31.5% for mid-thoracic tumors, and 14.4% for lower-thoracic tumors. Univariate analysis showed that cervical node metastasis was associated with tumor site, differentiation, and length, pathologic T status, and pN status (P<0.05); however, only tumor site and pN status retained significance in multivariate analysis (P<0.05). Positive cervical nodes were most often found in the paraesophageal region (72.3%), followed by supraclavicular (24.4%); involvement of deep cervical (2.4%) or retropharyngeal nodes (0.9%) was rare (P<0.0001). Positive cervical nodes were most often associated with upper TE-SCCs (60.1%), followed by middle TE-SCCs (31.2%) and lower TE-SCCs (10.6%). CONCLUSIONS: Upper TE-SCC with multiple involved nodes at any site was associated with a high rate of cervical node metastasis. These findings provide critical information for clinical decision-making regarding the extent of nodal dissection or the size of radiation fields in definitive radiotherapy.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Chen J, Cai W, Zheng X, et al. The pattern of cervical lymph node metastasis in thoracic esophageal squamous cell carcinoma may affect the target decision for definitive radiotherapy. Radiother Oncol. 2017. PMID: 28551110. doi:10.1016/j.radonc.2017.04.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。